PHP
CDMO

Parkman Healthcare Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Parkman Healthcare Partners’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-719,965
Closed -$8.19M – 103
2024
Q3 		$8.19M Buy
719,965
+98,874
+16% +$992K 1.05% 36
2024
Q2 		$4.43M Buy
621,091
+350,955
+130% +$2.68M 0.59% 60
2024
Q1 		$1.81M Buy
+270,136
New +$1.86M 0.22% 87
2023
Q4 		– Sell
-185,613
Closed -$1.75M – 108
2023
Q3 		$1.75M Buy
185,613
+7,713
+4% +$92.8K 0.32% 80
2023
Q2 		$2.49M Sell
177,900
-276,052
-61% -$4.71M 0.43% 64
2023
Q1 		$8.52M Buy
453,952
+25,684
+6% +$422K 1.85% 21
2022
Q4 		$5.9M Buy
428,268
+23,450
+6% +$359K 1.57% 20
2022
Q3 		$7.74M Sell
404,818
-56,408
-12% -$1.03M 2.2% 14
2022
Q2 		$7.04M Buy
461,226
+53,768
+13% +$795K 2.59% 12
2022
Q1 		$8.3M Buy
407,458
+117,458
+41% +$2.39M 2.43% 15
2021
Q4 		$8.46M Sell
290,000
-160,000
-36% -$4.58M 1.87% 20
2021
Q3 		$9.71M Sell
450,000
-25,000
-5% -$603K 2.46% 14
2021
Q2 		$12.2M Sell
475,000
-200,000
-30% -$4.27M 2.66% 12
2021
Q1 		$12.3M Sell
675,000
-74,511
-10% -$1.24M 2.86% 11
2020
Q4 		$8.65M Buy
749,511
+265,264
+55% +$2.43M 2.22% 15
2020
Q3 		$3.69M Buy
484,247
+359,247
+287% +$2.72M 0.98% 41
2020
Q2 		$821K Buy
+125,000
New +$698K 0.23% 73
2020
Q1 		– Sell
-140,523
Closed -$1.08M – 79
2019
Q4 		$1.08M Buy
+140,523
New +$820K 0.31% 62

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Parkman Healthcare Partners's CDMO Position: Q4 2024 in Review

Parkman Healthcare Partners sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 719,965 shares — an estimated $8.19M sold.

Parkman Healthcare Partners first reported a position in CDMO in Q4 2019 and held it in 18 quarters. The position peaked at $12.3M in Q1 2021. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Parkman Healthcare Partners reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 719,965 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $8.19M.
  • Parkman Healthcare Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
  • Parkman Healthcare Partners's Avid Bioservices, Inc. Common Stock position peaked at $12.3M in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Parkman Healthcare Partners's 13F filing for Q4 2024, filed 14 Feb 2025.